Feeds Biotechnologie

Will focus on responding to disasters and humanitarian crises, defending against biothreats, addressing climate change, and improving human health and performance.

Will focus on responding to disasters and humanitarian crises, defending against biothreats, addressing climate change, and improving human health and performance.

M-CELS are purpose-driven living systems with multiple interacting living components.

M-CELS are purpose-driven living systems with multiple interacting living components.

Fluorescent imaging technique simultaneously captures different signal types from multiple locations in a live cell.

MIT researchers identify a molecule that could target advanced prostate cancer as well as a variety of other cancers.

Gelatin-based microcarriers offer higher yield and scalability compared to existing commercial microcarriers.

Gelatin-based microcarriers offer higher yield and scalability compared to existing commercial microcarriers.

Mathematical analysis suggests that preventing large gatherings could significantly reduce Covid-19 infection rates.

Davis, in conversation with Senior Associate Dean Blanche Staton, fields questions from the MIT community about the current moment of racial reckoning.

Author Susan Hockfield, MIT president emerita and professor of neuroscience, receives 2020 Science Communication Award.

Author Susan Hockfield, MIT president emerita and professor of neuroscience, receives 2020 Science Communication Award.

MIT conference illustrates technologies developed in response to the pandemic and new opportunities for AI solutions for clinical management.

Immuneering uses bioinformatics to develop new medicines while also helping large pharmaceutical companies improve their treatments.

An online symposium explores roles for research universities and outlines the Institute’s efforts to be a testbed for research and policy innovations.

Despite the disruption caused by the pandemic, MIT students have carved out meaningful hands-on experiences.

Computational method for screening drug compounds can help predict which ones will work best against tuberculosis or other diseases.

Study finds that compressing cells, and crowding their contents, can coax them to grow and divide.

Biological engineer discusses condensing the time taken to develop therapeutics down from many years to a matter of months.

Biological engineer discusses condensing the time taken to develop therapeutics down from many years to a matter of months.

Michael Birnbaum, Anders Hansen, and Tami Lieberman receive NIH Director’s New Innovator Awards from the NIH Common Fund’s High-Risk, High-Reward Research program.

MIT researchers find blocking the expression of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.

New technology cuts cell culture time by half and uses more targeted cell sorting and purification methods.

New technology cuts cell culture time by half and uses more targeted cell sorting and purification methods.

Biomaterials pioneer considered “the premier biomedical engineer of the 20th century.”

A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard Covid-19 diagnostic.

SMART researchers find exposing bacteria to hydrogen sulfide can increase antimicrobial sensitivity in bacteria that do not produce H2S.

SMART researchers find exposing bacteria to hydrogen sulfide can increase antimicrobial sensitivity in bacteria that do not produce H2S.

Bacteria linked to Crohn’s disease are difficult to grow in the lab, but MIT engineers have found a way.

Fund has launched a special summer round to spearhead projects addressing mental health, well-being, and racial justice at MIT.

MIT researchers propose a design to overcome a major challenge in hydrocephalus catheters — clogging — by leveraging catheter geometry.

The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.

The company is developing treatments that restore gut bacteria in people struggling with a range of diseases.

MIT students explore algal water purifiers, programmable soil bacteria, and other biological engineering approaches to food and water security.

C3.ai Digital Transformation Institute awards $5.4 million to top researchers to steer how society responds to the pandemic.

In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.

New molecule for imaging calcium in neurons reduces crosstalk from neighboring neurons.

Computational modeling yields a protein fragment that could bind to coronavirus spike proteins and destroy them.

Research projects will harness the power of artificial intelligence to positively impact human health.

A new platform that precisely quantifies antigens presented on cell surfaces may help researchers and clinicians improve the effectiveness of cancer immunotherapies.

Graduating seniors and recent alumni will spend upcoming year abroad on Fulbright grants.

Multi-institutional MassCPR initiative announces more than $16.5 million to support 62 Boston-area projects.

Discovery explains why some bacteria have been able to defend against phage therapy, opens new ways to overcome existing challenges.

Students around the country recognized for innovative solutions to better single-use plastic, spacecraft and aircraft fuel gauges, surgery techniques, and more.

MIT professor and intensivist/trauma surgeon explains the new challenges that Covid-19 brings to treating patients in acute respiratory distress.

Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.

At MIT, senior Tarun Kamath has explored neuroscience and science policy, while helping his peers find ways to reduce stress.

Inaugural AI Powered Drug Discovery and Manufacturing Conference drew pharmaceutical companies, government regulators, and pioneering drug researchers.

The Audacious Project commitment will support the development of new classes of antibiotics to treat the world’s deadliest bacterial pathogens.

Manufacturability is key to producing a widely available, affordable vaccine.